Community Academic Profiles–

John Ioannidis

Back to Profile

Publication Details

  • Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention.

    Ioannidis JP, Karvouni E, Katritsis DG. J Am Coll Cardiol. 2003; 42 (8): 1406-11

    The aim of this study was to assess whether small creatine kinase-MB isoenzyme (CK-MB) elevations after percutaneous coronary intervention (PCI) affect the subsequent mortality risk.

    PubMedID: 14563583

Stanford Medicine Resources:

Footer Links: